The findings, published recently in Cell Reports Medicine, offer new clues to why some viral infections appear to trigger autoimmune disease.

Mass General Brigham head and neck cancer researchers are reporting in a new study in Clinical Cancer Research, on the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for diagnosing HPV-associated head and neck cancers, outperforming standard of care methods. HPV causes about 70% of oropharyngeal cancers in the U.S., which are increasing in incidence faster than other head and neck cancers.

Artificial intelligence tools can assist emergency room physicians in accurately predicting disease but only for patients with typical symptoms, West Virginia University scientists have found.